CDK4 and neoplasm: More specifically, CDK4/6 targeting (e.g., by abemaciclib) can drive tumor cells into proliferative quiescence (which is reversible); however, a reduced impact of mdm2 seems to be an essential mechanism for CDK4/6i-induced senescence, which is considered an irreversible precursor stage towards apoptosis [75,76].